304 related articles for article (PubMed ID: 35664436)
21. Integrative Bioinformatics Analysis Identifies NEK2 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma.
Liu S; Tian W; Li B
J Comput Biol; 2020 Jan; 27(1):100-108. PubMed ID: 31460782
[TBL] [Abstract][Full Text] [Related]
22. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study.
Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M
Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571
[TBL] [Abstract][Full Text] [Related]
23. FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma.
Liang H; Zhang C; Li C; Li C; Wang Y; Lin H
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34028536
[TBL] [Abstract][Full Text] [Related]
24. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
[TBL] [Abstract][Full Text] [Related]
25. Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
Chen YP; Wang YQ; Lv JW; Li YQ; Chua MLK; Le QT; Lee N; Colevas AD; Seiwert T; Hayes DN; Riaz N; Vermorken JB; O'Sullivan B; He QM; Yang XJ; Tang LL; Mao YP; Sun Y; Liu N; Ma J
Ann Oncol; 2019 Jan; 30(1):68-75. PubMed ID: 30407504
[TBL] [Abstract][Full Text] [Related]
26. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S
Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682
[TBL] [Abstract][Full Text] [Related]
27. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
28. Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes.
Liu Y; Liu N; Zhou X; Zhao L; Wei W; Hu J; Luo Z
Front Endocrinol (Lausanne); 2023; 14():1245629. PubMed ID: 37876534
[TBL] [Abstract][Full Text] [Related]
29. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
[TBL] [Abstract][Full Text] [Related]
30. Implications of Human Antimicrobial Peptide Defensin Beta-1 in Clinical Oral Squamous Cell Carcinoma Patients via an Integrated Bioinformatics Approach.
Li S; Li H; Xu Y; Ning W; Hu S; Wei S; Song H; Sun J; Ziebolz D; Schmalz G; Hu X; Liu M
Comput Math Methods Med; 2022; 2022():2203615. PubMed ID: 35222682
[TBL] [Abstract][Full Text] [Related]
31.
Dai Y; Chen W; Huang J; Cui T
Biomed Res Int; 2021; 2021():8874578. PubMed ID: 34285919
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive immunogenomic landscape analysis of prognosis-related genes in head and neck cancer.
Li L; Wang XL; Lei Q; Sun CZ; Xi Y; Chen R; He YW
Sci Rep; 2020 Apr; 10(1):6395. PubMed ID: 32286381
[TBL] [Abstract][Full Text] [Related]
33. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
34. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
35. Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma.
Li J; Ran H; Zeng X; Yang D; Zeng X; Zhang P
Medicine (Baltimore); 2023 Sep; 102(35):e35035. PubMed ID: 37657018
[TBL] [Abstract][Full Text] [Related]
36. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T
Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of the prognosis and biological significance of ROR
Zheng J; Tang H; Yang Y; Yang K
Environ Toxicol; 2024 Feb; 39(2):487-508. PubMed ID: 37278231
[TBL] [Abstract][Full Text] [Related]
38. Peroxisome proliferator-activated receptors signature reveal the head and neck squamous cell carcinoma energy metabolism phenotype and clinical outcome.
Yao Y; Wang D; Zhang Y; Tang Q; Xu Z; Qin L; Qu Y; Yan Z
J Gene Med; 2024 Jan; 26(1):e3605. PubMed ID: 37932968
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of the interferon regulatory factor (IRF) family and functional analysis of IRF11 in the large yellow croaker (Larimichthys crocea).
Guan Y; Chen X; Luo T; Ao J; Ai C; Chen X
Fish Shellfish Immunol; 2020 Dec; 107(Pt A):218-229. PubMed ID: 33011435
[TBL] [Abstract][Full Text] [Related]
40. Interferon regulatory factors inhibit TiLV replication by activating interferon-a3 in tilapia (Oreochromis niloticus).
Ke Z; Wen J; Wang Y; Li B; Wu S; Zhang D; Mo X; Li Y; Ren Y; Yin J; Shi C; Wang Q; Zheng S
Dev Comp Immunol; 2024 Jun; 155():105152. PubMed ID: 38408717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]